Ergomed has a long history of clinical trials in neuroscience, including neurology, pain and psychiatry.
We have conducted more than 90 studies in neuroscience indications involving 20,000 patients in sites across Europe, the US, the Middle East and north Africa, and the Asia Pacific.
Our teams and experts have strong relationships with key opinion leaders, sites and patient advocacy groups which are vital to developing the best strategies for clinical studies.
Our medical affairs team includes a certified neurologist with experience as an investigator and medical monitor across diverse indications within this therapeutic area.
In rare and orphan neurological diseases, our teams have been involved in trials for status epilepticus, Duchenne muscular dystrophy, amyotrophic lateral sclerosis (ALS), type 1 spinal atrophy, Huntington’s Disease and fragile X syndrome.
In psychiatry, we have run trials in major depressive disorder, postpartum depression, depression and anxiety disorders, ADHD, opioid dependency, PTSD, schizophrenia and obsessive-compulsive disorder.
In pain, our team has been involved in trials for neuropathic pain, migraine, musculoskeletal chronic pain, acute post-surgery pain, oncology pain and post-surgery acute pain.
Other neurological conditions where Ergomed had practical experience include multiple sclerosis, Parkinson’s disease, sleep disorders, sialorrhea, epilepsy and tremor.